Update: Safe handling of monoclonal antibodies in healthcare settings

Theme Cancer Pharmacists, Clinical Trials & Research Professionals
Resource Type Position Statement
DATE 10 March 2023

Update: Safe handling of monoclonal antibodies in healthcare settings

This position statement was published in the Asia Pacific Journal of Clinical Oncology, 10 March 2023, https://doi.org/10.1111/ajco.13943

The aims were to (a) review the scientific literature on occupational risk, including exposure mechanisms and risk assessment, with regards to handling monoclonal antibodies (mABs) in healthcare settings; and (b) update the recommendations in the Clinical Oncology Society of Australia (COSA) safe handling of monoclonal antibodies in healthcare settings position statement, published in 2013.

Practitioners should follow the 14 recommendations to lower occupational risk when handling mABs. Another Position Statement update should occur in 5–10 years to ensure the currency of recommendations.

DOWNLOAD

Join Australia's leading oncology community & make an impact

Become a COSA member

Twitter
@COSAoncology

COSAoncology 6 days ago

Our March member newsletter is out now. Check your inbox or log into your COSA account for the latest COSA news, member updates, journal articles and events. bit.ly/4j4unRT

COSAoncology 14 days ago

Check your inbox for the latest COSA Nutrition Group eNews. Or to subscribe, login to your COSA member account bit.ly/4cI0nc3 and update your preferences. Or members can view the eNews online anytime at bit.ly/4kYm5ww

COSAoncology 19 days ago

The take-out from Cancer Survivorship 2025 from co-convenor Bogda Koczwara. The conference theme was building capability and capacity in survivorship care and research. Courage, conviction, communication and collaboration were also firmly on display. #Surv25

COSAoncology 20 days ago

After two days of amazing participation from health professionals and consumers, co-convenor Michael Jefford is energised to build on the improvements we're seeing in survivorship care. #Surv25

COSAoncology 21 days ago

Congratulations to Best of the Best Poster Winner at #Surv25, Daniel Johnstone from Cancer Voices SA, for his poster, 'Patient-Teachers: A cancer-consumer informed approach to using stories of lived experience in healthcare student education.'

COSAoncology 21 days ago

Congratulations to Best of the Best Rapid Fire Oral Winner at #Surv25, Chad Han, for his presentation on 'Implementing a nurse-enabled, integrated, shared-care model involving specialists and GPs in breast cancer post-treatment follow up (EMINENT) bit.ly/4kGPtqS

COSAoncology 21 days ago

Congratulations to the Best of the Best Oral Winner at #Surv25, Ben Smith from the Daffodil Centre, for his presentation on 'Addressing fear of cancer recurrence in routine care: Feasibility of implementing a clinical pathway.' Read the paper: bit.ly/3XHO49L

COSAoncology 26 days ago

Cancer Survivorship 2025 - Day 1 of thought provoking presentations and stimulating discussions around important survivorship topics including financial toxicity, living with metastatic cancer, and providing tailored person-centred care. Bring on Day 2! #Surv25

COSAoncology 27 days ago

Our 2025 National Cancer Survivorship Conference begins tomorrow. Be prepared for an exciting program showcasing innovations in survivorship care, research, advocacy and policy. Plus opportunities to meet, mingle and collaborate. bit.ly/3F6okgT #Surv25

COSAoncology one month ago

The theme for COSA-IPOS 2025 in Adelaide in November is 'Optimising care, optimising outcomes – Partnering to improve outcomes for all'. For consideration in the program, submit your abstract by Friday 6 June 2025. For details: bit.ly/3XiOu6x #COSA25

Update: Safe handling of monoclonal antibodies in healthcare settings